Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTEIPA: Antibiotic Regimens for Early Pseudomonas Aeruginosa Infection in Bronchiectasis
NCT06368804Phase 2Recruiting
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciprofloxacin, colistimethate sodium in Pseudomonas aeruginosa infection, sponsored by Centre Hospitalier Intercommunal de Créteil. Started Sep 2024; status: recruiting.
02
Drugs
ciprofloxacincolistimethate sodium
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT06368804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06368804.